Aveanna Healthcare Q2 revenue beats on broad-based growth
Aveanna Healthcare Q2 revenue beats on broad-based growth
Overview
US home care provider's Q2 revenue rose 13.7%, beating analyst expectations
Adjusted EBITDA for Q2 increased 8.0% year-over-year
Company raised full-year 2026 revenue and adjusted EBITDA guidance
Outlook
Aveanna Healthcare raises full-year 2026 revenue guidance to greater than $2.68 bln
Company lifts full-year 2026 adjusted EBITDA guidance to greater than $365 mln
Aveanna cites strong segment performance and strategic execution for improved outlook
Result Drivers
SEGMENT GROWTH - Revenue increase driven by growth across PDS, HHH, and MS segments
ORGANIC GROWTH - Co cited strong organic growth across all three business segments
ACQUISITION IMPACT - Acquisition of Family First contributed to performance, per CFO
Company press release: ID:nGNX85vrth
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $670.50 mln | $638.62 mln (10 Analysts) |
Q2 EPS |
| $0.18 |
|
Q2 Net Income |
| $40.30 mln |
|
Q2 Adjusted EBITDA |
| $95.40 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Aveanna Healthcare Holdings Inc is $11.00, about 21.5% above its August 12 closing price of $9.05
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 10 three months ago
Reuters Recommended Reads
Aug 10 - P3 Health Partners lifts 2026 adjusted EBITDA outlook amid structural improvements
Aug 10 - Surgery Partners Q2 revenue beats on growth in same-facility segment
Aug 10 - Brookdale returns to Q2 profit as RevPAR rises
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Aveanna Healthcare Holdings
See all newsU.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare
U.S. STOCKS ON THE MOVE-NetEase, Werewolf Therapeutics, JP Morgan
U.S. STOCKS ON THE MOVE-Ubiquiti, BJ's Wholesale, Arbutus
U.S. STOCKS ON THE MOVE-Gold miners, Ross Stores, Stoke Therapeutics
Aveanna Healthcare drops as PE sponsor reduces stake